Developing new methods to create carbon-carbon bonds in organic compounds
Official title: Lewis Base Ligands Designed to Control Carbon-Carbon Bond Formation
Funded at Texas A&m University · NIH-10881756 · Data updated 2026-11-12
This study is looking at new ways to make important chemical connections that can help create better medicines and treatments for patients, using innovative techniques to make the process more efficient and effective.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m University NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project start | August 1, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $366,664 |
| NIH project number | 5R35GM151018-02 |
| Project ID | NIH-10881756 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals seeking innovative treatments for conditions that require advanced pharmaceutical interventions.
✕Less likely to help
Patients with conditions that do not rely on new organic compounds or synthetic medications may not receive direct benefits from this research.
What this research studies
This research focuses on advancing synthetic chemistry techniques to improve the formation of carbon-carbon bonds, which are essential in creating various organic compounds, including medicines and contraceptives. The approach involves innovative methods such as asymmetric synthesis and organocatalysis to enhance the efficiency and selectivity of these chemical reactions. By exploring new ligands and catalysts, the research aims to enable the conversion of less reactive carbon-hydrogen bonds into valuable carbon-carbon bonds, potentially leading to more effective therapeutic agents. Patients may benefit from the outcomes of this research through the development of improved medications and treatments derived from these advanced synthetic processes.
Why it matters
Potential benefit: If successful, this research could lead to the creation of more effective and targeted medications for various health conditions.
How similar studies have gone: Previous research in synthetic chemistry has shown significant advancements in drug development and organic synthesis, indicating a strong potential for success in this area.
Where this research is happening
-
Texas A&m University
College Station, United States Active
Researchers
- Principal investigator: Thomas, Andy Alexander — Texas A&m University
- Study coordinator: Thomas, Andy Alexander
Related research
Other NIH-funded projects on the same topics.
-
Astrocyte Clock and Daily Rhythms in Brain Function and Memory
This project explores how the brain’s support cells (astrocytes) and their daily clock affect learning, memory, and cognitive health, especially in conditions like Alzheimer’s disease.
-
Spatial ML tools for huge maps of tissue biology
A high-tech project develops scalable computer methods to analyze very large, spatially-resolved tissue data from patients.
-
Mirror-image RNA-binding reagents to study and modulate RNA in the lab
A scientist-led project to develop mirror-image RNA-binding molecules (L-aptamers) that can target RNA structures with high precision for basic science and potential therapies.
-
Cerebellum changes in aging and cognitive decline
Researchers are studying how aging affects the cerebellum and how these brain changes relate to moments of cognitive decline in people aged 65 and older.
-
GPI-anchor biosynthesis and sleep: how our genes shape your sleep
This project looks at how a specific gene pathway influences sleep in people and animal models to understand why sleep disorders happen.
-
Bayesian modeling of single-cell spatial data to find meaningful patterns in circadian-related affective disorders
A research team will use advanced Bayesian methods on single-cell spatial data to uncover how circadian rhythm disruptions may affect brain and body signals linked to mood and aggression in people with affective disorders.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.